To establish the link between Nrf2 and EpCAM in resistance, freshly isolated cisplatin resistant (n = 3) and sensitive (n = 3) patient tumor cells were subjected to flow cytometry analysis and quantified the EpCAM expression. Here, EPCAM is linked to neoplasm.